Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Sullivan

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Plos One|May 3, 2019
Biological variation in the sizes, shapes and locations of visual cortical areas in the mouseJack Waters, Eric Lee, Nathalie Gaudreault, et al.
Heart, Lung & Circulation|March 13, 2026
Barriers and Facilitators to Implementing Guideline Recommendations for Key Aspects of Familial Hypercholesterolemia Management in Australia: Primary Care Integration, Paediatric Management, and Treatment AdherenceMitchell Sarkies, Jo-Anne Manski-Nankervis, Shubha Srinivasan, et al.
Journal of Bacteriology|August 2, 2011
Genomes and characterization of phages Bcep22 and BcepIL02, founders of a novel phage type in Burkholderia cenocepaciaJason J Gill, Elizabeth J Summer, William K Russell, et al.
Transfusion|January 23, 2025
SARS-CoV-2 IgG antibodies in COVID-19 convalescent plasma and conventional plasma unitsAndrew Sulaiman, Isabella Sengsouk, Jodie L White, et al.
Cancers|October 14, 2022
Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by SimvastatinBlossom Mak, Hui-Ming Lin, Thy Duong, et al.
Lancet (London, England)|October 6, 2014
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trialFrederick J Raal, Evan A Stein, Robert Dufour, et al.
Nature Medicine|August 25, 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohortsGerald F Watts, Christian Schwabe, Russell Scott, et al.
Transfusion|October 21, 2022
Absence of pathogenic viruses in COVID-19 convalescent plasmaAbraham J Kandathil, Sarah E Benner, Evan M Bloch, et al.
Heart, Lung & Circulation|October 21, 2023
Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in AustraliaMitchell N Sarkies, Luke Testa, Stephanie Best, et al.
NEJM Evidence|February 6, 2024
RNA Interference Therapy Targeting Apolipoprotein C-III in HypertriglyceridemiaDaniel Gaudet, Peter Clifton, David Sullivan, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Plos One|May 3, 2019
Biological variation in the sizes, shapes and locations of visual cortical areas in the mouseJack Waters, Eric Lee, Nathalie Gaudreault, et al.
Heart, Lung & Circulation|March 13, 2026
Barriers and Facilitators to Implementing Guideline Recommendations for Key Aspects of Familial Hypercholesterolemia Management in Australia: Primary Care Integration, Paediatric Management, and Treatment AdherenceMitchell Sarkies, Jo-Anne Manski-Nankervis, Shubha Srinivasan, et al.
Journal of Bacteriology|August 2, 2011
Genomes and characterization of phages Bcep22 and BcepIL02, founders of a novel phage type in Burkholderia cenocepaciaJason J Gill, Elizabeth J Summer, William K Russell, et al.
Transfusion|January 23, 2025
SARS-CoV-2 IgG antibodies in COVID-19 convalescent plasma and conventional plasma unitsAndrew Sulaiman, Isabella Sengsouk, Jodie L White, et al.
Cancers|October 14, 2022
Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by SimvastatinBlossom Mak, Hui-Ming Lin, Thy Duong, et al.
Lancet (London, England)|October 6, 2014
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trialFrederick J Raal, Evan A Stein, Robert Dufour, et al.
Nature Medicine|August 25, 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohortsGerald F Watts, Christian Schwabe, Russell Scott, et al.
Transfusion|October 21, 2022
Absence of pathogenic viruses in COVID-19 convalescent plasmaAbraham J Kandathil, Sarah E Benner, Evan M Bloch, et al.
Heart, Lung & Circulation|October 21, 2023
Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in AustraliaMitchell N Sarkies, Luke Testa, Stephanie Best, et al.
NEJM Evidence|February 6, 2024
RNA Interference Therapy Targeting Apolipoprotein C-III in HypertriglyceridemiaDaniel Gaudet, Peter Clifton, David Sullivan, et al.
Pageof 19